INS and chronic hepatitis: Single-arm exploratory trial with 17 non-diabetic, lean chronic Hepatitis patients without significant fibrosis, treated with sofosbuvir/ledipasvir and ribavirin for 12 weeks. Insulin sensativity and cytokine levels were analyzed before and after treatment.